Mar 15, 2022 / 01:00PM GMT
Steven James Valiquette - Barclays Bank PLC, Research Division - Research Analyst
Next session will be with Centene. By the way, I'm Steven Valiquette, the health care services analyst here at Barclays. So welcome again, everybody, to day 1 of the conference. So with us from the company, we have Drew Asher, the CFO, and also Sarah London, Vice Chair.
This will be a fireside chat, but I think Sarah wants to make some comments upfront. So I'll turn it to you.
Sarah M. London - Centene Corporation - Vice Chairman
Great. Thanks, Steve. Thanks for having us. Great to see everyone in 3 dimension. I thought I might just give a quick update as a level set and then turn it back over to you for questions.
So as we said, Centene came into 2022 with strong momentum, thanks to good performance in the Medicare marketplace open enrollment periods, and that's really lined us up nicely against our membership targets. And then in the last 2 months, we've received RFP awards in Indiana and Louisiana, which I think speak to the differentiated value that we
Centene Corp at Barclays Global Healthcare Conference Transcript
Mar 15, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers